Subjects -> HEALTH AND SAFETY (Total: 1478 journals)
    - CIVIL DEFENSE (22 journals)
    - DRUG ABUSE AND ALCOHOLISM (87 journals)
    - HEALTH AND SAFETY (700 journals)
    - HEALTH FACILITIES AND ADMINISTRATION (358 journals)
    - OCCUPATIONAL HEALTH AND SAFETY (112 journals)
    - PHYSICAL FITNESS AND HYGIENE (117 journals)
    - WOMEN'S HEALTH (82 journals)

HEALTH AND SAFETY (700 journals)            First | 1 2 3 4     

Showing 201 - 203 of 203 Journals sorted alphabetically
Health Policy OPEN     Open Access  
Health Promotion International     Hybrid Journal   (Followers: 23)
Health Promotion Journal of Australia : Official Journal of Australian Association of Health Promotion Professionals     Full-text available via subscription   (Followers: 7)
Health Promotion Practice     Hybrid Journal   (Followers: 15)
Health Prospect     Open Access  
Health Psychology     Full-text available via subscription   (Followers: 59)
Health Psychology Bulletin     Open Access   (Followers: 1)
Health Psychology Research     Open Access   (Followers: 21)
Health Psychology Review     Hybrid Journal   (Followers: 46)
Health Research Policy and Systems     Open Access   (Followers: 15)
Health SA Gesondheid     Open Access   (Followers: 2)
Health Science Reports     Open Access   (Followers: 1)
Health Sciences and Disease     Open Access   (Followers: 1)
Health Security     Hybrid Journal   (Followers: 1)
Health Services Insights     Open Access   (Followers: 1)
Health Systems     Hybrid Journal   (Followers: 6)
Health Systems & Reform     Open Access   (Followers: 2)
Health Voices     Full-text available via subscription  
Health, Culture and Society     Open Access   (Followers: 13)
Health, Risk & Society     Hybrid Journal   (Followers: 11)
Health, Safety and Environment     Open Access   (Followers: 34)
Healthcare     Open Access   (Followers: 2)
Healthcare Quarterly     Full-text available via subscription   (Followers: 9)
Healthcare Technology Letters     Open Access  
HERD : Health Environments Research & Design Journal     Full-text available via subscription   (Followers: 1)
Highland Medical Research Journal     Full-text available via subscription  
Hispanic Health Care International     Full-text available via subscription  
Histoire, médecine et santé     Open Access   (Followers: 1)
Home Health Care Services Quarterly     Hybrid Journal   (Followers: 5)
Hong Kong Journal of Social Work, The     Hybrid Journal   (Followers: 3)
Horizonte Medico     Open Access  
Horizonte Sanitario     Open Access  
Hua Hin Sook Jai Klai Kangwon Journal     Open Access  
Human Nutrition & Metabolism     Open Access   (Followers: 1)
IEEE Journal of Translational Engineering in Health and Medicine     Open Access   (Followers: 5)
IISE Transactions on Occupational Ergonomics and Human Factors     Hybrid Journal  
IJS Global Health     Open Access  
Implementation Science     Open Access   (Followers: 22)
Implementation Science Communications     Open Access   (Followers: 4)
IMTU Medical Journal     Full-text available via subscription  
Indian Journal of Health Sciences and Biomedical Research KLEU     Open Access   (Followers: 2)
Indian Journal of Youth and Adolescent Health     Open Access  
Indonesian Journal for Health Sciences     Open Access   (Followers: 1)
Indonesian Journal of Public Health     Open Access  
Infodir : Revista de Información científica para la Dirección en Salud     Open Access  
interactive Journal of Medical Research     Open Access  
International Archives of Health Sciences     Open Access  
International Health     Hybrid Journal   (Followers: 5)
International Health Trends and Perspectives     Open Access  
International Journal for Equity in Health     Open Access   (Followers: 10)
International Journal for Quality in Health Care     Hybrid Journal   (Followers: 39)
International Journal of Applied Behavioral Sciences     Open Access   (Followers: 1)
International Journal of Behavioural and Healthcare Research     Hybrid Journal   (Followers: 8)
International Journal of Child Development and Mental Health     Open Access   (Followers: 2)
International Journal of Circumpolar Health     Open Access   (Followers: 2)
International Journal of Community Medicine and Public Health     Open Access   (Followers: 3)
International Journal of E-Health and Medical Communications     Full-text available via subscription   (Followers: 2)
International Journal of Environmental Research and Public Health     Open Access   (Followers: 22)
International Journal of Evidence-Based Healthcare     Hybrid Journal   (Followers: 8)
International Journal of Food Safety, Nutrition and Public Health     Hybrid Journal   (Followers: 20)
International Journal of Growth and Development     Open Access   (Followers: 1)
International Journal of Health & Allied Sciences     Open Access   (Followers: 3)
International Journal of Health Care Quality Assurance     Hybrid Journal   (Followers: 13)
International Journal of Health Economics and Management     Hybrid Journal   (Followers: 10)
International Journal of Health Geographics     Open Access   (Followers: 7)
International Journal of Health Policy and Management     Open Access   (Followers: 11)
International Journal of Health Professions     Open Access   (Followers: 3)
International Journal of Health Promotion and Education     Hybrid Journal   (Followers: 11)
International Journal of Health Research     Open Access   (Followers: 4)
International Journal of Health Sciences     Open Access  
International Journal of Health Sciences Education     Open Access   (Followers: 2)
International Journal of Health Services     Full-text available via subscription   (Followers: 7)
International Journal of Health System and Disaster Management     Open Access   (Followers: 4)
International Journal of Healthcare     Open Access  
International Journal of Healthcare Delivery Reform Initiatives     Full-text available via subscription   (Followers: 1)
International Journal of Healthcare Information Systems and Informatics     Hybrid Journal   (Followers: 6)
International Journal of Healthcare Management     Hybrid Journal   (Followers: 14)
International Journal of Healthcare Policy     Hybrid Journal   (Followers: 1)
International Journal of Hygiene and Environmental Health     Hybrid Journal   (Followers: 7)
International Journal of Indigenous Health     Open Access   (Followers: 5)
International Journal of Kinesiology in Higher Education     Hybrid Journal  
International Journal of MCH and AIDS     Open Access  
International Journal of Medicine and Health Development     Open Access   (Followers: 4)
International Journal of Mens Social and Community Health     Open Access  
International Journal of Mental Health     Full-text available via subscription   (Followers: 24)
International Journal of Practice-based Learning in Health and Social Care     Open Access   (Followers: 1)
International Journal of Prevention and Treatment     Open Access   (Followers: 1)
International Journal of Public Health Research and Management     Hybrid Journal   (Followers: 5)
International Journal of Public Health Science     Open Access   (Followers: 6)
International Journal of Scientific Reports     Open Access   (Followers: 3)
International Journal of Sexual Health     Hybrid Journal   (Followers: 3)
International Journal of Social Welfare     Hybrid Journal   (Followers: 18)
International Journal of Spa and Wellness     Hybrid Journal  
International Journal of Telerehabilitation     Open Access   (Followers: 1)
International Journal of Yoga : Philosophy, Psychology and Parapsychology     Open Access   (Followers: 6)
International Research in Children's Literature     Hybrid Journal   (Followers: 4)
Internationale Revue Fur Soziale Sicherheit     Hybrid Journal   (Followers: 1)
InterScientia     Open Access  
Investigaciones Andina     Open Access  
Iranian Journal of Health and Environment     Open Access  
Iranian Journal of Public Health     Open Access  
Israel Journal of Health Policy Research     Open Access  
İzmir Katip Çelebi Üniversitesi Sağlık Bilimleri Fakültesi Dergisi     Open Access  
JAMA Health Forum     Open Access  
JBI Evidence Implementation     Full-text available via subscription   (Followers: 4)
JBI Evidence Synthesis     Hybrid Journal   (Followers: 5)
Jeugd en Co     Hybrid Journal  
JGZ Tijdschrift voor jeugdgezondheidszorg     Hybrid Journal   (Followers: 2)
JMIR Human Factors     Open Access   (Followers: 4)
JMIR Public Health and Surveillance     Open Access  
JMIR Serious Games     Open Access   (Followers: 8)
Jornal Brasileiro de TeleSSaúde     Open Access  
Jornal de Ciências da Saúde do Hospital Universitário da Universidade Federal do Piauí     Open Access   (Followers: 3)
Journal Health NPEPS     Open Access  
Journal of Advances in Environmental Health Research     Open Access   (Followers: 2)
Journal Of Allied Health     Full-text available via subscription   (Followers: 7)
Journal of Behavior, Health & Social Issues     Open Access   (Followers: 8)
Journal of Behavioral Addictions     Open Access   (Followers: 5)
Journal of Behavioral Health Services & Research     Hybrid Journal   (Followers: 15)
Journal of Biology, Agriculture and Healthcare     Open Access   (Followers: 2)
Journal of Charoenkrung Pracharak Hospital     Open Access  
Journal of Child Sexual Abuse     Hybrid Journal   (Followers: 61)
Journal of Communication in Healthcare     Hybrid Journal   (Followers: 3)
Journal of Community Health     Hybrid Journal   (Followers: 9)
Journal of Community Medicine and Primary Health Care     Open Access   (Followers: 4)
Journal of Consumer Health on the Internet     Hybrid Journal   (Followers: 4)
Journal of Creativity in Mental Health     Hybrid Journal   (Followers: 13)
Journal of Developing Areas     Full-text available via subscription   (Followers: 5)
Journal of Development Effectiveness     Hybrid Journal   (Followers: 5)
Journal of Dr. NTR University of Health Sciences     Open Access  
Journal of Earth, Environment and Health Sciences     Open Access   (Followers: 2)
Journal of Eating Disorders     Open Access   (Followers: 14)
Journal of Education and Health Promotion     Open Access   (Followers: 4)
Journal of Environment Pollution and Human Health     Open Access   (Followers: 3)
Journal of Epidemiology & Community Health     Hybrid Journal   (Followers: 64)
Journal of Epidemiology and Public Health     Open Access   (Followers: 4)
Journal of Ergonomics     Open Access   (Followers: 8)
Journal of Evolution and Health : An Ancestral Health Society Publication     Open Access  
Journal of Exercise & Organ Cross Talk     Open Access   (Followers: 4)
Journal of Exercise Science & Fitness     Open Access   (Followers: 24)
Journal of Family & Consumer Sciences     Full-text available via subscription  
Journal of Family Medicine and Primary Care     Open Access   (Followers: 11)
Journal of Family Social Work     Hybrid Journal   (Followers: 12)
Journal of Family Strengths     Open Access   (Followers: 3)
Journal of Fasting and Health     Open Access   (Followers: 1)
Journal of Global Health     Open Access   (Followers: 2)
Journal of Health and Social Behavior     Hybrid Journal   (Followers: 27)
Journal of Health Care Chaplaincy     Hybrid Journal   (Followers: 3)
Journal of Health Design     Open Access   (Followers: 1)
Journal of Health Disparities Research and Practice     Open Access   (Followers: 2)
Journal of Health Economics and Outcomes Research     Open Access   (Followers: 2)
Journal of Health Policy and Management     Open Access   (Followers: 2)
Journal of Health Promotion     Open Access   (Followers: 1)
Journal of Health Psychology     Hybrid Journal   (Followers: 57)
Journal of Health Research     Open Access  
Journal of Health Research and Reviews     Open Access  
Journal of Health Science     Open Access   (Followers: 3)
Journal of Health Science and Alternative Medicine     Open Access   (Followers: 1)
Journal of Health Science and Community Public Health     Open Access  
Journal of Health Science and Medical Research     Open Access  
Journal of Health Science and Prevention     Open Access  
Journal of Health Science Research     Open Access  
Journal of health sciences     Open Access  
Journal of Health Sciences     Open Access  
Journal of Health Sciences and Medicine     Open Access  
Journal of Health Sciences and Surveillance System     Open Access  
Journal of Health Sciences Scholarship     Open Access  
Journal of Health Service Psychology     Full-text available via subscription   (Followers: 1)
Journal of Health Services and Education     Open Access  
Journal of Health, Population and Nutrition     Open Access   (Followers: 13)
Journal of Healthcare Informatics Research     Hybrid Journal   (Followers: 2)
Journal of Healthcare Risk Management     Hybrid Journal   (Followers: 10)
Journal of Human Health     Open Access   (Followers: 1)
Journal of Human Trafficking     Open Access   (Followers: 29)
Journal of Ideas in Health     Open Access   (Followers: 1)
Journal of Immigrant and Minority Health     Hybrid Journal   (Followers: 8)
Journal of Industrial Safety Engineering     Full-text available via subscription   (Followers: 6)
Journal of Infection and Public Health     Open Access   (Followers: 4)
Journal of Integrated Care     Hybrid Journal   (Followers: 18)
Journal of Integrated Health Sciences     Open Access   (Followers: 4)
Journal of Interprofessional Education & Practice     Full-text available via subscription   (Followers: 5)
Journal of Law and Health     Open Access   (Followers: 8)
Journal of Manmohan Memorial Institute of Health Sciences     Open Access  
Journal of Medical and Health Studies     Open Access   (Followers: 2)
Journal of Mental Health Counseling     Full-text available via subscription   (Followers: 8)
Journal of Multidisciplinary Healthcare     Open Access   (Followers: 6)
Journal of Multidisciplinary Research in Healthcare     Open Access   (Followers: 2)
Journal of Muslim Mental Health     Open Access   (Followers: 6)
Journal of Nanotheranostics     Open Access  
Journal of Nursing & Interprofessional Leadership in Quality & Safety     Open Access   (Followers: 5)
Journal of Occupational Health     Open Access   (Followers: 1)
Journal of Occupational Health Psychology     Full-text available via subscription   (Followers: 39)
Journal of Occupational Science     Hybrid Journal   (Followers: 27)
Journal of Oral Health and Craniofacial Science     Open Access  
Journal of Patan Academy of Health Sciences     Open Access  
Journal of Prevention and Health Promotion     Full-text available via subscription  
Journal of Preventive Medicine and Public Health     Open Access   (Followers: 1)
Journal of Primary Prevention     Hybrid Journal   (Followers: 7)
Journal of Psychosexual Health     Open Access  
Journal of Public Child Welfare     Hybrid Journal   (Followers: 8)

  First | 1 2 3 4     

Similar Journals
Journal Cover
International Journal of Health Professions
Number of Followers: 3  

  This is an Open Access Journal Open Access journal
ISSN (Print) 1895-1066 - ISSN (Online) 2296-990X
Published by Sciendo Homepage  [370 journals]
  • Processes and experiences of satellite haemophilia clinic set-ups in
           Uganda – a short report

    • Abstract: Haemophilia knowledge and care are largely missing in much of sub-Saharan Africa and there is a need for concerted efforts to ensure access to care services by affected persons. Haemophilia Foundation Uganda, supported by the global haemophilia community and working with the Uganda Ministry of Health, has set up eight satellite haemophilia treatment centres (HTCs) as part of a wider initiative to raise awareness and improve haemophilia care. Setting up the HTCs has involved a six-step process involving stakeholders in government, healthcare and the community, and ranging from securing initial support to an ongoing follow-up programme of mentorship and training. Over 1,700 healthcare professionals have been trained and 186 patients have been registered at these peripheral facilities over the past five years. This is helping to improve access to care, but there are still shortcomings around diagnostic capacity, available healthcare personnel, and facilities to procure recombinant factor products. We will continue and further our advocacy for budgetary inclusion of haemophilia at political and facility levels. We also propose a continued strengthening of the haemophilia care teams through mentorship, networking, and mobilisation for diagnostic support at large public hospitals.
      PubDate: Fri, 20 May 2022 00:00:00 GMT
       
  • Discrete choice experiments: An overview of experience to date in
           haemophilia

    • Abstract: BackgroundThe patient voice is an important consideration in the availability and choice of pharmaceuticals – however, how to capture this complex area and apply it formally within regulation, health technology assessment and reimbursement remains subject to ongoing debate. Patient preference studies such as discrete choice experiments (DCEs) are being utilised more frequently in healthcare and it is anticipated that patient preference data will be incorporated more frequently into regulatory submissions moving forward.AimThe aim of this review is to provide an overview of DCEs conducted within haemophilia to date and to consider the key issues in response to a rapidly evolving therapeutic pathway.MethodsA systematic literature search was undertaken via Ovid MEDLINE and EMBASE CLASSIC + EMBASE. s were uploaded and analysed via Rayyan systematic review software. Results: Of 478 records identified from the database searches, 12 full text journal articles met the inclusion criteria with a date range from 2005–2021. There have been two published studies exploring haemophilia patient preferences in relation to gene therapy: one DCE and one utilising a threshold technique. Surveyed audiences included physicians, patients, pharmacists, healthcare professionals and caregivers. 50% of the included studies (n=6) were exclusively conducted in the US, whilst 3 recruited participants across multiple countries. The sample size varied considerably between studies with the total sample size ranging from 30 participants to 505 participants. For the studies involving patients and their caregivers, the mean patient age range was 8.2–41.4 years. There was diversity in (a) the scale of the qualitative work undertaken to support the DCEs, (b) the undertaking of pilots, and (c) how extensively these elements were reported in the included studies. There is a notable trend towards using an online web-based format, with 3 out of 4 DCEs since 2019 utilising this approach. The number of attributes observed per DCE ranged from 5–12 with a median of 6 attributes from the included studies. The number of levels per attribute was relatively consistent (range 2–5) with 2–3 (n=4) and 2–4 levels (n=4) being utilised most frequently.ConclusionPatient preferences and the methods for capturing these are likely to be subject to ongoing debate as the haemophilia care pathway evolves to offer more therapeutic options with a range of risks and benefits. Whilst techniques such as DCE are effective at quantifying patient preferences, they tell us little about the reasons driving these decisions and the likelihood that they will change in response to temporal or external factors. DCEs could be particularly useful for estimating the uptake of new products and assessing potential budget impact. Accelerated and reformed regulatory processes are likely to increase demand for patient preference studies. There is therefore an increased requirement to ensure that patient advocacy groups (PAGs) are resourced and have the expertise to support these studies alongside other research commitments, and that manufacturers consider collaborative approaches when formally capturing patient preferences.As more therapeutic options become available in haemophilia care, discrete choice experiment may be a useful means of gauging patient preference© Shutterstock
      PubDate: Fri, 20 May 2022 00:00:00 GMT
       
  • Point of care ultrasonography in patients with haemophilia and acute
           haemarthrosis: a physiotherapist and sonographer inter-professional
           agreement pilot study

    • Abstract: BackgroundHaemophilia treatment centres (HTCs) around the world are increasingly adopting point-of-care ultrasonography (POCUS) for the assessment of acute haemarthrosis and to monitor joint health. POCUS is in large part administered by physiotherapists in most comprehensive care teams. Appropriate implementation of haemophilia-specific POCUS requires an educational foundation and training to ensure competency and optimal outcomes. Inter-professional agreement and evaluation of image quality are important measures of competency and acceptable use of POCUS.AimsTo determine the level of agreement between physiotherapist and sonographer-performed POCUS scans and to compare the quality of the ultrasound images obtained by physiotherapists to those obtained by the sonographer.MethodsThis single blind, prospective, pilot study recruited patients with haemophilia A and B who presented to clinic with a suspected acute haemarthrosis of the elbow, knee, or ankle and consented to participate. POCUS scans were performed by one trained physiotherapist and one sonographer in the haemophilia ambulatory clinic at patient presentation, one-week follow-up, and two-week follow-up. The physiotherapist participated in formal training consisting of 12 hours of online didactic modules and a two-day, 12-hour practical module with instructor-led hands-on training. For the primary objective, the outcome of interest was the binary decision on the presence or absence of blood within the joint. For the secondary objective, image quality was evaluated by the radiologist post hoc and rated as optimal, acceptable, or sub-optimal.ResultsThirteen participants with haemophilia consented to the study. The results indicated an excellent level of agreement (k=0.80) with an observed agreement of 91.7%, a specific positive agreement of 94.1%, and a specific negative agreement of 85.7% for the detection of blood within the joint space. The quality of the ultrasound images obtained by the physiotherapist were rated by the radiologist as optimal (84.6%) and acceptable (15.4%). None of the images were rated as sub-optimal.ConclusionOptimal image quality and a high level of agreement between the physiotherapist and sonographer-performed POCUS for the assessment of acute hemarthrosis in people with haemophilia A and B was observed. These results suggest that, with a short formal training programme, physiotherapists can be proficient in the performance, acquisition, and interpretation of POCUS scans in patients with haemophilia.
      PubDate: Fri, 20 May 2022 00:00:00 GMT
       
  • Treatment of a patient with severe haemophilia A presenting with left
           extra pleural haematoma and diagnosed with inhibitors – case report

    • Abstract: Haemophilia is an inherited X-linked bleeding disorder characterised by a deficiency or absence of clotting factor VIII (haemophilia A) or IX (haemophilia B), which can cause musculoskeletal bleeding. The standard treatment for haemophilia is with factor concentrates to replace the missing or deficient clotting factor. However, there is a risk that the immune system develops antibodies against the exogenous factor, known as inhibitors. Managing patients with haemophilia and inhibitors who develop bleeding in unusual sites can be challenging for the treating physician. Here, we present a rare case of patient with severe haemophilia A who was diagnosed with inhibitors after developing bleeding in the left posterior chest wall (extra pleural haematoma). The patient was successfully managed with activated prothrombin complex concentrate (aPCC) (FEIBA: FVIII inhibitor bypassing activity; Baxter AG), and the pain and swelling gradually resolved over three weeks. This case emphasises the importance of clinical suspicion of inhibitor formation in a patient already diagnosed with haemophilia A presenting with unusual bleeding that does not respond to standard treatment.
      PubDate: Fri, 20 May 2022 00:00:00 GMT
       
  • Development of decision-making considerations to support equitable patient
           selection in paediatric haemophilia trials

    • Abstract: BackgroundClinical trials for investigational haemophilia treatments such as gene therapy offer a potentially life-changing opportunity to those who are selected for enrolment. However, the number of enrolment slots available for these trials is often greatly exceeded by the number of eligible patients. Many of the strategies that are commonly used to select candidates for participation can be highly unsystematic, inequitable, and subjective. A more rigorous set of criteria is therefore needed to evaluate each candidate's suitability for trial participation in order to eliminate bias in selection and fulfill the ethical principle of justice.AimsTo review current knowledge and issues in patient selection for paediatric haemophilia clinical trials with competitive availability, and to develop a more objective standard for decision-making that takes into account the needs of all involved parties.MethodsA literature search on the ethics of trial participant selection and the practice of fairly distributing limited medical resources was conducted to identify previous literature and best practices in the area. A list of essential decision-making considerations was then designed to guide the selection of paediatric participants for haemophilia therapy trials through iterative group discussions between a diverse team of health professionals at McMaster Children's Hospital, Hamilton, ON, Canada.ResultsCurrent practices in resolving this ethical issue are highly heterogenous, although there are some common themes and recommendations. The three main criteria supported by the team and the literature search for inclusion in the considerations were: medical need, need for support, and potential safety considerations for the patient. Three measures for evaluating each criterion were developed and added for consideration during the decision-making process. The role of patient selection in meeting the scientific aims of the trial was also considered.ConclusionAttempting to create an equitable, systematic decision-making procedure for clinical trial participant selection involves a wide variety of competing values and ethical considerations, and discrepancies between recommendations are commonplace. The criteria presented here are intended to be used as a guideline to assist the equitable selection of paediatric patients for participation in haemophilia clinical trials with highly limited enrolment, although it may have some applicability to other areas of clinical research or therapeutic areas concerned with the allocation of scarce medical resources. Next steps should involve speaking with patients, community members and other stakeholders in order to include their perspectives.Assessment of medical need, potential support needs, and safety considerations form the basis of criteria for discussions around how to make enrolment in paediatric haemophilia clinical trials more equitable© Shutterstock
      PubDate: Fri, 08 Apr 2022 00:00:00 GMT
       
  • Key challenges for hub and spoke models of care – A report from the 1st
           workshop of the EHC Think Tank on Hub and Spoke Treatment Models

    • Abstract: IntroductionThe hub and spoke model can deliver high quality care to a scattered population through centres of expertise supported by a network of several smaller geographically dispersed centres. This approach is now being proposed to provide care for people with rare diseases, and in particular for rare bleeding disorders. To ensure that specialised treatments such as gene therapy can be delivered effectively using the hub and spoke model of care, it is important to understand the challenges that the model presents for all stakeholders.Identifying key challengesAs part of the EHC Think Tank Workstream on Hub and Spoke Treatment Models, 14 stakeholders representing health care providers, patient groups, research and industry met in November 2021 to identify challenges in the design, implementation and sustainable operation of hub and spoke models, and to propose ways in which resources could be allocated and collaboration fostered, from each of their stakeholder perspectives. Five key challenges were identified: 1. How future care might be re-envisioned; 2. Which agencies and stakeholders should determine which centres become hubs or spokes, and how this process might be carried out; 3. Identifying the criteria that will define a hub and spoke, and the roles of various stakeholders in that process; 4. How resources might be allocated; 5. How hubs and spokes will collaborate to ensure that patients' needs are prioritised. This model may also be recommended for treatment with gene therapy in certain rare diseases.SummaryHub and spoke models should be implemented by establishing criteria for hub and spoke status, prioritising patients in service reorganisation and in the care pathway, and considering the impact of new service models on current arrangements. The next step is to vet the challenges identified by this workstream with a broader group of external stakeholders and bring their perspectives back for consideration.
      PubDate: Tue, 29 Mar 2022 00:00:00 GMT
       
  • Osseous bilateral pseudotumour of the thumb in severe haemophilia A
           – A case report

    • Abstract: Pseudotumour is a rare complication of haemophilia, categorised as osseous or non-osseous (soft tissue) lesions based on anatomic location. The bones most frequently involved are the larger ones; pseudotumours of small bones are rare. Here we present a rare case of pseudotumours of both thumbs in a 10-year-old male with severe haemophilia A, successfully treated with factor replacement therapy. This case highlights the possibility of treating such cases conservatively, but also the need for education to enable early intervention to prevent potential complications that could be life-threatening.
      PubDate: Tue, 29 Mar 2022 00:00:00 GMT
       
  • Patient agency: key questions and challenges – A report from the 1st
           workshop of the EHC Think Tank Workstream on Patient Agency

    • Abstract: IntroductionPatient agency refers to the abilities and capabilities of patients to act, contribute, influence and make decisions about their healthcare. It depends on both the willingness of patients to participate and the constraints imposed by healthcare providers, services and systems. To determine the factors affecting patient agency, especially for patients with chronic, rare diseases such as haemophilia requiring lifelong care, it is important to consider the patterns, structures, and mental models that define the ecosystem that patients are a part of, irrespective of their level of engagement.Identifying key challengesAt the first workshop of the EHC Think Tank Workstream on Patient Agency in December 2021, participants identified five key themes for in-depth discussion relevant to patient agency: the concept of shared decision-making (SDM), patient empowerment, the spectrum of engagement, cultural change and health literacy. The Iceberg Model was used to unpack challenges by identifying composite factors on four levels: events, patterns, structures and mental models.SummaryAcross the five themes, four common perceived challenges stand out: uneven relationships between patients and healthcare professionals, services and systems; paternalism and hierarchical cultures; failure to recognise problems; conservatism and resistance to change. Despite some progress towards patient empowerment, a ‘glass ceiling’ prevents patients from driving transformation and taking leadership roles in strategy, policymaking and governance. Patient engagement is fluid and those who could benefit most are least likely to engage. Health literacy is perceived as the problem of the patient, not the system, and patients rather than healthcare providers are typically expected to adapt. Preliminary suggestions for addressing these challenges include behavioural communication training for patients and healthcare professionals, a learning system for empowered patient and family care, and a level playing field for stakeholders to interact equally, leading to mutual acceptance and respect.
      PubDate: Tue, 29 Mar 2022 00:00:00 GMT
       
  • New challenges for an expanding generation of older persons with
           haemophilia

    • Abstract: BackgroundIncreasing survival among people with haemophilia means that more individuals are at risk of developing age-related morbidity. Little is known about morbidity and health-related quality of life (HRQoL) in different age groups within a single large population of people with haemophilia.AimThis study aimed to explore the association between increasing age and comorbidity among people with haemophilia and to compare their HRQoL with that of a sample of the general population in England.MethodsThe prevalence of comorbidity recorded in medical records and HRQoL assessed by EQ-5D were compared by age group in participants in the Cost of Haemophilia in Europe: A Socioeconomic Survey study (CHESS) in Europe. HRQoL was compared with that of a sample of the general population taken from the 2012 Health Survey for England (HSE).ResultsYounger adults in CHESS were more likely to have received prophylaxis from an early age. The mean number of affected joints in younger adults was 1.0; participants aged 41–50 (1.25) and 51–60 years (1.41) had the highest mean number of affected joints. The prevalence of comorbidity was 36% in patients aged 18–30, 61% in 31–60-year-olds and 68% in those aged 61+. HRQoL impairment in young adults with haemophilia was comparable with that in the HSE population aged over 60.ConclusionsOlder people with haemophilia have impaired quality of life compared with younger adults and an increasing prevalence of several age-related disorders affecting mental health and cardiovascular and bone health. Young adults with haemophilia report impaired HRQoL comparable with that in a general population aged 61+.
      PubDate: Wed, 09 Mar 2022 00:00:00 GMT
       
  • Key challenges for patient registries – A report from the 1 workshop of
           the EHC Think Tank Workstream on Registries

    • Abstract: IntroductionPatient registries are an invaluable resource for furthering the understanding of rare diseases such as bleeding disorders, providing large, pooled datasets not achievable by other means of data collection. As well as supporting clinical care and research, registries must also be able to answer questions that are important to the wider bleeding disorders community. However, there are challenges associated with the need for secure access, exchange of health data, quality and interoperability, and data delivery.Identifying key challengesAs part of the EHC Think Tank Patient Registries Workstream, 17 stakeholders representing health care providers, patient groups, research and industry met in October 2021 to identify challenges to managing and utilising patient registries, from each of their stakeholder perspectives. This is a first step in a longer term process aiming to identify or co-create solutions that could improve access and interpretation of patient data. The challenges identified relate to five key categories which are interlinked in various ways: 1. The multiplicity of registries and datasets; 2. Data quality; 3. Data sharing; 4. Expanding the scope of registries; 5. The role of the patient in registries.SummaryThe heterogeneity in the way that registries are designed, funded and owned, the type of data collected, and the way data is collected are issues that must be addressed. Good, quality data is needed at all levels to ensure the provision and funding of effective care. Data quality will increase overall if it is possible to merge data from different registries. The value of patient participation in registries must also be acknowledged and built on to help ensure their quality, that they remain fit for purpose, and that data input is sustained over time.
      PubDate: Wed, 09 Mar 2022 00:00:00 GMT
       
  • Seeing the bigger picture: Qualitative research in the Zoom age

    • Abstract: Participants in clinical trials for new haemophilia treatments are routinely asked to complete quality of life (QoL) questionnaires using validated and disease-specific instruments. Yet too often in clinical research we know very little about the life stories of individuals, making it difficult to know how they have been affected by a new therapy and what exactly has changed for the better – or for the worse. In my own research, I wanted to understand the differences that new treatments are really making to people's everyday lives. While traditional QoL instruments can be helpful, using a qualitative approach that involves speaking directly with people with haemophilia (PwH) and their family members has enabled me find out what has really been going on their lives, including impacts on the wider family. The Covid pandemic and the need to maintain social distancing changed the way in which my research has been carried out, but in fact provided an opportunity to see an even bigger picture. I believe that using videoconferencing platforms to conduct interviews and focus groups has both allowed me to see more of the world in which the participants live and has enabled participants to be more relaxed and open in their conversations, resulting in a potentially richer dataset. While this approach to qualitative QoL research should not replace interviews and focus groups, the use of videoconferencing should be considered as another methodology researchers can and should use to enable them to glean the richest data possible. Qualitative interviews offer an important complementary addition to the validated QoL measures used in clinical trials, enabling us to hear more about where improvements have occurred, where further improvements can be made, and the real-life impact of a new treatment for PwH and their families.
      PubDate: Thu, 30 Dec 2021 00:00:00 GMT
       
  • Telemedicine in haemophilia during COVID-19 and beyond: a comprehensive
           review

    • Abstract: IntroductionPatients with haemophilia require regular assessments and physical examinations. The COVID-19 pandemic has resulted in the rapid adoption of telemedicine to enable virtual consultations and reduce hospital visits. However, the process of virtual consultations is new to many haemophilia clinics. A better understanding of best practices in telemedicine is important to ensure optimal quality of care for patients with haemophilia.ObjectivesTo summarise the current literature on the use of direct-to-consumer telemedicine for patients with haemophilia and to describe the effectiveness and potential limitations of the technology and methods used.MethodsA comprehensive search was conducted in MEDLINE and EMBASE databases using terms referring to the concepts “haemophilia” AND “telemedicine” and their synonyms. There were no time or language restrictions. Title, abstracts, and full texts were screened. Included articles involved telemedicine interventions to facilitate clinical services directly between patients and providers without the use of third-party personnel. The primary outcome was the satisfaction of providers and patients. Secondary outcomes included economic considerations and clinical outcomes. Information was extracted based on study-specific, patient-specific, intervention-specific, and outcome-specific data.ResultsOf the 925 articles screened, six were identified and summarised. Three described telemedicine within the context of COVID-19. Technologies used included telephone calls, videoconferencing, text messaging, and email. All studies involved a multidisciplinary team. Telemedicine in haemophilia care was found to positively impact the patient experience. Providers were satisfied with telemedicine. It was also suggested to be economically beneficial and positively impacted patient outcomes. However, none of the articles reported on how telemedicine was specifically used to perform assessments during the virtual consultation process.ConclusionsThere is preliminary evidence that telemedicine may be beneficial in haemophilia care. Overall, patients and providers reported high satisfaction with the usage of direct-to-consumer telemedicine. This positive reception warrants improvements in standardisation of reporting and quality of study design to better assess its clinical and economic impact. Developing a standard guideline for virtual consultations would support healthcare practitioners in how to best incorporate telemedicine to improve quality of care.
      PubDate: Thu, 14 Oct 2021 00:00:00 GMT
       
  • The use of rIX-FP in patients with haemophilia B: a nurse's perspective

    • Abstract: The management of patients with haemophilia is complex and requires lifelong care to be delivered by a specialist multidisciplinary team. Haemophilia B results from a deficiency or absence in coagulation factor IX (FIX), leading to easy bruising, and musculoskeletal and internal bleeding. For patients with severe or moderate haemophilia B, prophylaxis with standard half-life (SHL) coagulation FIX products requires frequent intravenous administration, which may negatively impact treatment adherence and increase burden of care. A recombinant fusion protein linking recombinant FIX (rFIX) with recombinant human albumin, rIX-FP, has an extended half-life compared with SHL rFIX, and has demonstrated a favourable safety and efficacy profile for the prevention and treatment of bleeding episodes in phase III and real-world studies of patients with severe haemophilia B. rIX-FP enables treatment to be tailored to the needs of individual patients, with dosing flexibility allowing selected patients to be treated with prophylaxis dosing intervals of 7, 10, 14 or 21 days. Patients switching to rIX-FP can reduce their annualised bleeding rate and some have successfully reduced their prophylactic dosing frequency while maintaining low bleeding rates and consistent factor consumption. This may ultimately minimise the occurrence of haemophilic arthropathy and improve patient quality of life. Educating patients and caregivers on the sustained use of rIX-FP prophylaxis is essential. The lifelong support and guidance provided by healthcare professionals at haemophilia treatment centres (HTCs) are critical for providing an optimal treatment approach that can increase adherence to treatment. This article reviews the pharmacokinetics, efficacy, and safety of rIX-FP demonstrated in clinical trials and clinical practice, and discusses haemophilia nurses’ clinical experiences with rIX-FP in patients in their HTCs.
      PubDate: Wed, 18 Aug 2021 00:00:00 GMT
       
  • Red Flag Study: An observational cross-sectional survey looking at
           bleeding in patients with a bleeding disorder who are lost to follow-up

    • Abstract: BackgroundRegular follow-up visits and routine care is important for people with a mild bleeding disorder in terms of lowering their risk of complications from untreated bleeds and helping them maintain a healthy lifestyle. However, follow-up visits among this population can sometimes be missed for unclear reasons.AimThe present study aimed to question if lost-to-follow-up patients with a bleeding disorder experience unreported but important bleeding events that are not communicated to their haemophilia treatment centre (HTC) and if they could benefit from more frequent clinic visits.MethodsA multicentre paper-based cross-sectional survey was sent to people diagnosed with an inherited blood disorder and lost to follow-up for two years or more. Those who met the eligibility criteria received the survey by mail and completed and returned it to their HTC between October 2015 and July 2016.ResultsInvitation packages were sent to 71 individuals; 14 questionnaires returned, with a survey response rate of 19.7%. Of the 14 returned surveys, only 11 participants were eligible who either responded completely or partially to the survey. Quality of life was reported as almost never or never a problem by all but one participant, who limited activities due to bleeding problems. Spontaneous nosebleeds were sometimes, often or always a problem for three participants; one female participant reported issues associated with heavy menstrual bleeding as often or almost always a problem.ConclusionWe concluded that although the mean annual bleeding self-reported events were relatively low, they cannot be underestimated when keeping in mind the limitations and challenges of accessing data among this population. Our study highlighted the importance of educating this group of patients on their bleeding disorder and engaging them in their own care and health status, which may result in improving their health-related quality of life and overall health outcomes.
      PubDate: Sun, 30 May 2021 00:00:00 GMT
       
  • Dental extraction in congenital factor Vll deficiency with inhibitor
           – a case report

    • Abstract: BackgroundHereditary factor VII (FVII) deficiency is a rare bleeding disorder with autosomal recessive inheritance, and FVII deficiency with an inhibitor is extremely rare. There is sparse information in the literature on the management of tooth extraction in patients with FVII deficiency and an inhibitor.Case descriptionWe report the case of a five-year-old child with FVII deficiency and an inhibitor who underwent dental extraction. The child had had multiple bleeding episodes including intracranial haemorrhage and had a history of severe allergic reaction to the infusion of recombinant FVII. The tooth was extracted using lignocaine gel and the antifibrinolytic agent oral tranexamic acid.ConclusionThe extraction of a deciduous tooth in a patient with FVII deficiency and an inhibitor was undertaken without bleeding complications. There are currently no guidelines regarding management of this type of case. Further studies and evidence are required so that management can be standardised.
      PubDate: Sun, 30 May 2021 00:00:00 GMT
       
  • The impact of heavy periods on women with a bleeding disorder

    • Abstract: BackgroundWomen with a bleeding disorder (WBD), including those diagnosed as a carrier, often have heavy periods associated with prolonged bleeding and pain. This survey sought to describe the impact of this substantial burden on daily living and the personal cost of managing heavy periods.MethodsAn online survey was promoted to women who identify as having a bleeding disorder via the social media of The Haemophilia Society in January and February 2020. The survey included 20 questions about personal data, symptoms and the practicalities of living with a bleeding disorder.ResultsA total of 181 responses were received, of which 151 were complete questionnaires. Of these, 58% of respondents were aged 18–45 and 136 identified as having a bleeding disorder, mostly haemophilia or von Willebrand disease. Thirteen (10%) had been diagnosed as a haemophilia carrier and a further four women were probable carriers. Prolonged or painful periods were reported by the majority of respondents; the median duration of bleeding was 7 days (range 2–42). Thirty-six per cent took time off work or study as a result and 42% reported a negative impact on social life. Eighteen women (13%) reported having to use a combination of sanitary protection products to manage their bleeding. Women diagnosed as a carrier reported morbidity comparable with that of women with a diagnosed bleeding disorder and reported greater use of combinations of sanitary protection.ConclusionWBD experience a high prevalence of heavy bleeding and prolonged, painful periods despite using appropriate symptomatic treatment. The impact of heavy periods on women diagnosed as a being a carrier is comparable with that experienced by women with a diagnosed bleeding disorder, but as they are not always clinically recognised they may lack access to care and support.
      PubDate: Sun, 02 May 2021 00:00:00 GMT
       
  • Case report of nasal pseudotumor – a rare presentation in severe
           haemophilia A with high titre inhibitors

    • Abstract: Haemophilia patients with inhibitors suffer from increased morbidity and mortality due to the ineffectiveness of factor VIII replacement. Pseudotumors are rare but dangerous complications in these patients, and nasal pseudotumors are even rarer. Here, we present the case of a young child with severe haemophilia A with high titre inhibitors who developed a nasal pseudotumor. When immune tolerance therapy was not possible due to financial constraints, he was treated with FEIBA prophylaxis and rituximab. The pseudotumor was managed with surgical excision. We conclude that epistaxis in haemophiliacs can be due to an underlying nasal pseudotumor, and highlight the use of rituximab for the eradication of inhibitors.
      PubDate: Wed, 03 Mar 2021 00:00:00 GMT
       
  • “It's a way of life”: Results from the Perceptions of Pain in
           Haemophilia study

    • Abstract: IntroductionPain is recognised as a subjective phenomenon, often defined as ‘whatever the experiencing person says it is, existing whenever the experiencing person says it does’. Pain is a critical aspect of life for many people with haemophilia (PWH) but is under-recognised and inconsistently managed by clinicians. As haemophilia management moves towards non-factor-based treatments which may normalise life experience, it is unclear how this will impact on the experience and management of pain.AimsThe Perceptions of Pain in Haemophilia study aimed to identify the impact of pain on men with haemophilia in the UK.MethodsThe study used mixed qualitative research methods (paper-based questionnaires and focus group interviews). Eligible PWH aged >18 years were invited to participate in a focus group to discuss pain, assessment and management. Each focus group discussion was recorded, transcribed and analysed thematically.ResultsEighteen participants (13 haemophilia A (12 severe) and 5 severe haemophilia B) age range 18–58 years (median 32.5 years) joined focus groups conducted using an online video platform. The majority (95%) were treated with prophylaxis and reported few recent bleeds. Three main themes emerged: the impact of pain, managing pain, and factors influencing the experience of pain. Participants connected their earliest experiences of pain with childhood; it impacted their mental health and wellbeing, daily habits, routines, sports, hobbies, social life, work and education. Participants recognised the difference between the pain of acute bleeds and arthritic pain. Many did not like taking strong analgesics due to side-effects and concerns around addiction. Participants doubted the value of pain scales and noted a lack of empathy and understanding among health care professionals (HCPs), but valued physiotherapists. Participants recognised the value of talking about the negative impact of their pain experiences; however, they reported that family members, who often provided the most support, could not always truly understand their pain.ConclusionPain is ‘normal’ for PWH, who adopt it into part of their everyday life experience. HCPs are ideally placed to impact this experience but seem to lack insight as to the extent of pain and how to manage it beyond prescribing stronger analgesia. The social and psychological implications of chronic pain should be better addressed by HCPs. This includes being cognisant that new therapeutic options will not resolve old pain.
      PubDate: Fri, 01 Jan 2021 00:00:00 GMT
       
  • Haemophilia A management with emicizumab: A survey of haematologists in
           the United States

    • Abstract: BackgroundEmicizumab is a bispecific monoclonal antibody approved in the United States (US) for the treatment of people with haemophilia A (PwHA) with or without factor VIII (FVIII) inhibitors. Changes to haematologists’ practices since the approval of emicizumab are of interest to the haemophilia A community.AimTo identify the clinical characteristics of PwHA receiving emicizumab (PwHArE) in the real-world setting and gain insight into the disease management practices of haematologists treating PwHArE.MethodsIn total, 50 haematologists across the US completed a one-time, 30-minute, online, qualitative survey consisting of 55 questions (including 11 screening questions) in May 2019. Haematologists were required to be board-certified in haematology, practising in the US, ≥2 years post-residency experience, and currently treating ≥3 PwHA with emicizumab.ResultsHaematologists reported their PwHArE were mostly adults (aged ≥18 years; 66%) with severe phenotypes (66%), with and without FVIII inhibitors. Haematologists perceived that PwHArE had similar or better treatment adherence (40% and 50%, respectively) compared with PwHA on other treatments, sought the same or lower levels of routine care (72% and 14%, respectively), and were similarly or more physically active (52% and 32%, respectively). Additionally, most haematologists currently using immune tolerance induction (ITI) in PwHArE reported using lower doses of FVIII (73%) and shorter durations (45%) for ITI.ConclusionsAvailability of emicizumab has resulted in changes in the care of PwHArE, including bleed management, FVIII monitoring, activity guidance, surgery, and use of ITI. Understanding patterns of disease management can inform clinical care.
      PubDate: Fri, 01 Jan 2021 00:00:00 GMT
       
  • Bone health assessment in haemophilic arthropathy: A single centre study
           from Kolkata, West Bengal, India

    • Abstract: BackgroundHaemophilia has been associated with increased prevalence of low bone mineral density (BMD) which in turn may aggravate haemophilic arthropathy. Dual-energy X-ray absorptiometry (DEXA) is the gold standard for assessing BMD but is not widely available across India. Markers of bone turnover like bone-specific alkaline phosphatase (b-ALP) reflect osteoblastic turnover and may be surrogate to low BMD.AimTo evaluate how bone health in people with haemophilia (PWH) can be assessed by serum vitamin D3 and b-ALP level, correlated with the degree of arthropathy.MethodsIn this cross-sectional study, people with haemophilia A and B of all severities with arthropathy involving ≥3 joints were included. The number of joints affected by haemophilic arthropathy was recorded. Hemophilia Joint Health Score (HJHS) and Pettersson score were calculated for each patient. Levels of serum calcium, phosphorus, vitamin D3 and b-ALP were assayed in all cases.ResultsA total of 320 PWH were included; the majority (85%; 272/320) had severe haemophilia, 13.44% (43/320) moderate haemophilia and 1.56% (5/320) mild haemophilia. With increasing age, the number of joints involved increased significantly (r=0.2250, p<0.05). When adjusted for age, b-ALP was higher than normal for the majority of PWH (88.75%). Increased number of joints involved and severity of disease had a positive correlation with higher-than-normal b-ALP (adjusted for age) (r=0.2112, p=0.0001). A significant positive correlation was seen between Pettersson score and HJHS score (r=0.1126, p=0.04). There was no significant correlation between number of joints involved and serum vitamin D3 level across the whole cohort. (p<0.05).ConclusionPWH with severe disease and haemophilic arthropathy have higher than normal b-ALP, which in turn reflects increased bone turn over and low BMD. Hence, b-ALP may be a useful marker to help assess bone health in PWH, particularly in settings where access to DEXA scans is constrained.
      PubDate: Fri, 01 Jan 2021 00:00:00 GMT
       
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
 


Your IP address: 3.238.24.209
 
Home (Search)
API
About JournalTOCs
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-